429673-79-0

Basic information

• Product Name: TRANS-3-AMINO-1-BOC-4-METHOXYPYRROLIDINE
• Synonyms: TRANS-3-AMINO-1-BOC-4-METHOXYPYRROLIDINE ;trans-3-Amino-4-methoxy-pyrrolidine-1-carboxylic acid tert-butyl ester;trans-tert-Butyl 3-amino-4-methoxypyrrolidine-1-carboxylate;(3S,4S)-tert-butyl 3-amino-4-methoxypyrrolidine-1-carboxylate;tert-butyl (trans)-3-amino-4-methoxy-1-pyrrolidinecarboxylate(SALTDATA: HCl);tert-butyl (trans)-3-amino-4-methoxy-1-pyrrolidinecarboxylate 1HCl;(3R,4R)-rel-3-AMino-4-Methoxy-1-pyrrolidinecarboxylic Acid 1,1-DiMethylethyl Ester;tert-butyl (3R,4R)-3-amino-4-methoxypyrrolidine-1-carboxylate
• CAS NO: 429673-79-0
• Molecular Formula: C10H20N2O3
• Molecular Weight: 216.2774
• Mol File: 429673-79-0.mol

Chemical Properties

• Boiling Point: 287.413°C at 760 mmHg
• Flash Point: 127.623°C
• Appearance: /
• Density: 1.098g/cm³
• Vapor Pressure: 0.002mmHg at 25°C
• Refractive Index: 1.494
• Storage Temp.: 2-8°C(protect from light)
• CAS DataBase Reference: TRANS-3-AMINO-1-BOC-4-METHOXYPYRROLIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: TRANS-3-AMINO-1-BOC-4-METHOXYPYRROLIDINE(429673-79-0)
• EPA Substance Registry System: TRANS-3-AMINO-1-BOC-4-METHOXYPYRROLIDINE(429673-79-0)

Safety Data

• Hazardous Substances Data: 429673-79-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
TRANS-3-AMINO-1-BOC-4-METHOXYPYRROLIDINE is used as a synthetic intermediate for the development of anti-tumor agents. Its unique molecular structure allows for the creation of novel compounds with potential anti-cancer properties, contributing to the ongoing efforts in the fight against various types of cancer.
In the synthesis of anti-tumor agents, TRANS-3-AMINO-1-BOC-4-METHOXYPYRROLIDINE serves as a crucial building block, enabling the development of new pharmaceuticals with enhanced efficacy and selectivity against cancer cells. Its incorporation into the molecular structure of these agents can lead to improved pharmacokinetic properties, reduced side effects, and increased potency, ultimately benefiting patients undergoing cancer treatment.

InChI:InChI=1/C10H20N2O3/c1-10(2,3)15-9(13)12-5-7(11)8(6-12)14-4/h7-8H,5-6,11H2,1-4H3/t7-,8-/m0/s1